PubMed Health⌕ Search

Biomedical subjects

A Dame

Publications and source records attributed to A Dame.

14 recordsLinked to original sources

Asynchronous regional brain volume losses in presymptomatic to moderate AD.

To determine if rates and locations of brain volume loss associated with AD are phase-specific, occurring prior to clinical onset and at later stages, we performed longitudinal volumetric MRI analysis on 155 subjects enrolled in a prospective study of aging and dementia. Subjects were divided by Clinical Dementia Rating (CDR) scale into stages of Normal (CDR 0 --> 0), Very Mild (CDR 0 --> 0.5 and 0.5 --> 0.5), Mild (CDR 0.5 --> 1.0 and 1.0 --> 1.0) and Moderate (CDR 1.0 --> 2.0 and 2.0 --> 2.0) dementia. Rates of volume change in CSF spaces, lobar and medial temporal lobe regions were analyzed for group differences across stages. Annual rates of ventricular volume change differed between non-demented and very mild group (p<0.01). In later severity stages, ventricular, temporal, basal ganglia-thalamic region and total volumes show change. Rates of volume loss increase as dementia progresses, but not uniformly in all regions. These regional and phase-specific volume changes form targets for monitoring disease-modifying therapies at clinically relevant, defined stages of dementia.

Aged↗

Natural history of cognitive decline in the old old.

OBJECTIVE: To prospectively examine the occurrence and outcome of cognitive decline in healthy, community-dwelling elders. METHODS: Ninety-five elders (mean age 84 years) who at entry had no cognitive impairment were followed for up to 13 years. Cognitive decline was defined as obtaining either a Clinical Dementia Rating (CDR) = 0.5 or Mini-Mental State Examination (MMSE) score < 24 on two examinations. RESULTS: Three outcomes of aging were determined: intact cognition, persistent cognitive decline without progression to dementia, and dementia. Whereas 49% remained cognitively intact, 51% developed cognitive decline. Mean follow-up to first CDR 0.5 was 3.8 years and age at conversion was 90.0 years. Those who remained cognitively intact had better memory at entry and were less likely to have APOE4 than those who developed cognitive decline. Of the 48 participants with cognitive decline, 27 (56%) developed dementia (CDR > or =1) a mean of 2.8 years later. Participants with cognitive decline who progressed to dementia had poorer confrontation naming at the time of their first CDR 0.5 than those with persistent cognitive decline who did not progress during follow-up. CONCLUSION: The old old are at high risk for developing cognitive decline but many will not progress to dementia in the next 2 to 3 years or even beyond. These findings are important for understanding the prognosis of cognitive decline and for the design of treatment trials for AD. APOE genotype is a risk factor for cognitive decline.

Aged↗

Predictors of healthy brain aging.

To determine if superior health at old age protects against cognitive impairment (CI) and Alzheimer's disease (AD), we prospectively studied 100 optimally healthy oldest-old (> or =85 years) individuals. Initially, subjects represented the top 3% of the oldest old for health. During 5.6 +/- 0.3 years of follow-up, 34 subjects developed CI, and 23 progressed to AD. By age 100, probability of CI and AD were.65 +/-.09 and.49 +/-.10. Median onset age was 97 years for CI and 100 for AD. Clearly, superior health at old age does not guarantee protection against cognitive decline. Lifetime risks were similar to the general population but onset ages were later, suggesting factors that delay onset are key to improving cognitive health in the elderly. In this population, absence of apolipoprotein E-epsilon4 and male gender were associated with delayed onset, whereas estrogen use and education had no detectable effect on cognitive outcome.

Age of Onset↗

Longitudinal analysis of the effects of the aging process on neuropsychological test performance in the healthy young-old and oldest-old.

A sample of 33 young-old (ages 65 to 74) and 20 oldest-old (ages 84 to 93) healthy elderly without dementia were assessed with neuropsychological tests annually over a 4-year period to examine longitudinal changes in cognitive functioning. Significant age-group differences existed at baseline in participants' performances on tests of immediate memory and visuospatial skills. There were no age-group differences in the rate of change over the 4-year interval on any neuropsychological tests. Within each age-group, the amount of change over time was minimal for most tests though some practice effects were apparent, and on some tests mild decline was observed. Results suggest that healthy old adults, including the oldest-old, do not experience measurable declines in cognitive functioning over a 4-year period.

Age Factors↗

Factors associated with brain donation among optimally healthy elderly people.

BACKGROUND: Consent rates for brain donation were examined in 140 healthy elderly participants of the Oregon Brain Aging Study, a longitudinal study of successful aging. Subjects were initially selected for good health. The study population had a relatively high education level, a high socioeconomic status, and were predominantly white. METHODS: At each annual examination, a project physician asked participants to consider brain donation. This analysis examined variables that may affect the rate of brain donation consent: age, gender, education, socioeconomic status, marital status, religiosity, cognitive status, depression, and functional status. RESULTS: Of these variables only age was a meaningful factor. CONCLUSION: The oldest old participants (> or =85 years of age) were more likely to consent to donation than the younger participants (65-84 years of age).

Age Factors↗

Cognitive markers preceding Alzheimer's dementia in the healthy oldest old.

OBJECTIVE: To look for preclinical markers of Alzheimer's dementia in a sample of healthy, oldest old individuals. DESIGN: Prospective, longitudinal study of individuals examined at yearly intervals with neuropsychological tests selected to be sensitive to the early detection of dementia. PARTICIPANTS: One hundred and thirty-nine community-dwelling, functionally independent, healthy individuals 65 to 106 years of age who met strict criteria for lack of dementia at entry. Incident dementia cases consisted of 16 volunteers all 80 years old or older who developed dementia of the Alzheimer's type and 31 volunteers 80 years old and older showing no evidence of dementia during a mean 2.8-year follow-up interval. MEASUREMENTS: Scores on 10 neuropsychological measures were analyzed for the initial examination when none of the volunteers showed clinical evidence of dementia and for the two subsequent yearly examinations. RESULTS: Individuals who subsequently developed dementia showed evidence of verbal memory impairment at their initial examination, which was a mean of 2.8 years before clinical evidence of dementia. The average yearly incidence rate for dementia in those 80 years of age and older was 12%. Performance of individuals who did not development dementia remained relatively stable during follow-up for up to 5 years. CONCLUSION: Alzheimer's disease has a preclinical stage in which verbal memory decline is the earliest sign. Dementia in the oldest old is distinguishable from age-related cognitive decline.

Aged↗

Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia.

OBJECTIVE: To determine initial locus and rate of degeneration of temporal lobe structures (total lobe, hippocampus and parahippocampus) in preclinical dementia. BACKGROUND: Postmortem studies suggest that the earliest changes in Alzheimer's disease are neurofibrillary tangle formation in hippocampus and adjacent cortex. MRI volume analysis of temporal lobe structures over time in subjects prior to developing dementia may allow the identification of when these processes begin, the rate they develop, and which areas are key to symptom development. METHODS: 30 nondemented (NoD), healthy, elderly individuals enrolled in a prospective study of healthy aging evaluated annually over a mean of 42 months. Twelve subjects with subsequent cognitive decline were assigned to the preclinical dementia group (PreD). All 120 annual MRI studies analyzed by volumetric techniques assessed group differences in temporal lobe volumes and rates of brain loss. RESULTS: NoD as well as PreD subjects had significant, time-dependent decreases in hippocampal and parahippocampal volume. Rates of volume loss between the groups did not significantly differ. PreD cases had significantly smaller hippocampi when asymptomatic. Parahippocampal volume did not differ between PreD and NoD cases. Significant time-dependent temporal lobe atrophy was present only in PreD. CONCLUSIONS: Hippocampal and parahippocampal atrophy occurs at a similar rate regardless of diagnostic group. Those who develop dementia may have smaller hippocampi to begin with, but become symptomatic because of accelerated loss of temporal lobe volume. Temporal lobe volume loss may mark the beginning of the disease process within six years prior to dementia onset.

Aged↗

A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.

The oldest old are the fastest-growing segment of our population and have the highest prevalence of dementia. Little is known about the genetics of cognitive health in the very old. The aim of this study was to determine whether the genetic risk factors for Alzheimer disease (AD)--namely, apolipoprotein E (APOE) epsilon4 allele and a family history of dementia-continue to be important factors in the cognitive health of the very old. Case-control studies suggest that the effect of genetic factors diminishes at age >75 years. The present prospective study provided evidence to the contrary. We studied 114 Caucasian subjects who were physically healthy and cognitively intact at age 75 years and who were followed, for an average of 4 years, with neurological, psychometric, and neuroimaging examinations. Excellent health at entry did not protect against cognitive decline. Incidence of cognitive decline rose sharply with age. epsilon4 and a family history of dementia (independent of epsilon4) were associated with an earlier age at onset of dementia. Subjects who had epsilon4 or a family history of dementia had a ninefold-higher age-specific risk for dementia than did those who had neither epsilon4 nor a family history of dementia. These observations suggest that the rate of cognitive decline increases with age and that APOE and other familial/genetic factors influence the onset age throughout life.

Age of Onset↗

Age-related changes in behavioral components in relation to changes in global Type A behavior.

The current study is one of a series of studies undertaken to investigate long-term changes of the Type A behavior pattern (TABP) in surviving subjects of the Western Collaborative Group Study. Behavioral components were scored for 565 Structured Interviews (SI) of returning subjects using a recently developed methodology. Scores were compared with component ratings from the 1960-1961 intake interviews to isolate specific elements of change and evaluate their magnitude in relation to changes in global TABP. Test-retest correlations for seven behavioral components of the SI support the notion of moderate stability ranging in value from .29 to .55. Significant mean changes in component scores were observed for Type A Content, Exactingness, Competitiveness, and Hostility. Changes in Competitiveness and Hostility were Type A dependent, showing reliable increases in Type A subjects but not in Type B subjects. The observed changes in Hostility, Competitiveness, and Exactingness support the overall change in the Type A direction observed in previous analyses of these data.

Adult↗

The Rationality/Emotional Defensiveness Scale--II. Convergent and discriminant correlational analysis in males and females with and without cancer.

The psychological correlates of the Rationality/Emotional Defensiveness Scale and its two subscales were examined in 1236 males and 863 females from the Western Collaborative Group Study. An additional 157 males and 164 females with some form of cancer other than of the skin were also included in this analysis. Characteristics measured included self-reported emotional control, anger expression, trait personality, depressive and neurotic symptomatology, Type A behavior, hostility, and social desirability. Results indicate that the Rationality/Emotional Defensiveness Scale is most strongly related to the suppression and control of emotions, especially anger. Scores on this scale also tend to be associated with less Type A behavior and hostility and with more social conformity. Analysis of the component subscale suggests that Antiemotionality, i.e. the extent to which an individual uses reason and logic to avoid interpersonally related emotions, is most strongly marked by the control of anger, while Rationality, i.e. the extent to which an individual uses reason and logic as a general approach to coping with the environment, is related to the control of anxiety and a higher level of trait curiosity. The psychological interpretation of the scale appears to be largely invariant across gender, unaffected by residualization of the total scale score for its association with Social Desirability, and, except for a few minor instances, unrelated to the diagnosis of cancer.

Aged↗

Long-term changes in Type A behavior: a 27-year follow-up of the Western Collaborative Group Study.

This study examined the long-term stability of Type A behavior pattern in the Western Collaborative Group Study for 1180 surviving participants in a 27-year follow-up examination during 1986-1987. Subjects were readministered the Structured Interview (SI), originally developed for this study and first administered at intake in 1960-1961. Subjects were also given the Jenkins Activity Survey (JAS) and were asked to evaluate their behaviors currently and in the past using two short descriptions of Type A and Type B behaviors. Analyses of changes in global SI ratings, JAS score, and self-ratings showed no relationships between self-perceived changes reported in questionnaires and observed changes when assessed by the SI. Using the SI ratings, 61% of subjects retained their initial classification and 39% of subjects were rated differently, with a higher percentage of those originally typed B being rerated as A than A being rerated as B. Type B subjects rerated as A were significantly younger, retired earlier, reported better health, and were less likely to have been in a managerial or professional position than the subjects who changed from A to B.

Adult↗

The Rationality/Emotional Defensiveness Scale--I. Internal structure and stability.

In a 10-year prospective study, Grossarth-Maticek and colleagues reported that the tendency to repress and/or deny emotions was strongly predictive of cancer mortality. The method used to assess repression/denial was modified recently by Spielberger to form the Rationality/Emotional Defensiveness (R/ED) Scale. The present study investigates the psychometric properties of the R/ED Scale in 1236 male (mean age = 71.8 yr) and 863 female (mean age = 68.5 yr) participants in a 27-year follow-up of the Western Collaborative Group Study. Analyses revealed high interitem consistency (Cronbach's alpha = 0.77 and 0.78 for men and women, respectively) and two independent and stable factors that we labeled 'Anti-emotionality' (27% of total variance) and 'Rationality' (21% of total variance). Excluding cancer subjects, significant gender differences were observed for individual items, total R/ED score, and the two subscales. Comparisons of the 159 male cancer patients and the 175 female cancer patients with the corresponding noncancer subjects suggest possible gender x cancer status and age x cancer status interactions. These results challenge Grossarth-Maticek's assertion that rationality/anti-emotionality is a unidimensional construct and indicate the need to take into account the effect of age and gender on the presence of these psychological constructs.

Aged↗

27-year mortality in the Western Collaborative Group Study: construction of risk groups by recursive partitioning.

The relationship of selected biological and behavioral characteristics measured at baseline examination to 27-year mortality due to coronary heart disease (CHD), cancers of all sites, and total mortality in the 3154 men that form the Western Collaborative Group Study was investigated using tree-structured survival analysis or recursive partitioning (RP). Intake (1960-61) characteristics included in the present analyses were age, serum cholesterol, systolic blood pressure (SBP), cigarette smoking, body mass index (BMI), Type A/B behavior, and behavioral hostility. Tree-structured survival analysis for CHD mortality partitioned the cohort into six groups and identified five groups with distinct survival experience. Exceptionally high CHD mortality rates (17.3 and 14.6 per thousand) were experienced by 89 older men with elevated hostility ratings and SBP less than or equal to 150, and 238 men whose initial SBP was greater than 150 mmHg. Younger men (age less than or equal to 48) with SBP less than or equal to 150 and with serum cholesterol levels greater than 227 had a death rate of 4.8 per thousand, compared with a rate of 1.7 in similar men with lower cholesterol levels. Applied to 27-year cancer mortality, the RP algorithm partitioned the cohort into four distinct survival groups. Younger (age less than 45) Type B men had superior survival compared with Type A men of similar ages, and the proportion of ever cigarette smokers in these two groups was not statistically different. The results obtained by tree-structured survival analyses were compared with results obtained by Cox regression survival analyses.

Adult↗

Involuntary retirement, Type A behavior, and current functioning in elderly men: 27-year follow-up of the Western Collaborative Group Study.

Data from 1,103 community-dwelling male participants (mean age = 71.7 years) in a 27-year cardiovascular disease follow-up were used to examine health and mental health sequelae in voluntarily and involuntarily retired Type A individuals. After controlling for age, education, and occupation, Type A subjects, determined both at intake (1960-1961) and at follow-up (1986-1987), reported significantly more frequently that retirement was involuntary. Regardless of Type A status, those reporting involuntary retirement also tended to have poorer adjustment to retirement, more illness, poorer physical status, and more depressive symptomatology. Minimal evidence was obtained on a broad array of indicators for psychological, physical, cognitive, and health status that Type As who retired involuntarily fared worse in retirement than those who retired voluntarily.

Activities of Daily Living↗